E-Cigarette Flavors for Electronic Cigarette Use
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to examine how different e-cigarette flavors—specifically sweet and cooling—affect sensations, appeal, and value, with a special focus on differences between men and women. Participants will try three different nicotine-containing e-liquid flavors (E-liquid Flavor 1, E-liquid Flavor 2, and E-liquid Flavor 3) in a randomized order across three visits. Current cigarette smokers who have used e-cigarettes at least 10 times in the past 6 months, are not trying to quit, and have no untreated chronic conditions might be a good fit for this study. As an unphased trial, this study offers a unique opportunity to contribute to understanding e-cigarette flavor preferences and their effects.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people with non-stable prescription medications. It's best to discuss your specific situation with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that e-cigarette flavorings, such as those in E-liquid Flavor 1, E-liquid Flavor 2, and E-liquid Flavor 3, can affect the body in various ways. Some flavors might be safe to eat but not safe to inhale, as the lungs process substances differently than the stomach. Studies have found that inhaling e-cigarette vapors exposes users to harmful chemicals. For instance, some e-liquids contain chemicals like formaldehyde, known to cause cancer, and other substances that can damage the lungs.
In E-liquid Flavor 2, flavorings such as diacetyl have been linked to serious lung disease. Concerns also exist about nicotine, which can harm the heart and brain. Using these e-liquids carries risks, including potential lung and heart issues.
For E-liquid Flavor 3, a review found that while some flavor compounds are safe to eat, inhaling them can still be risky. The chemicals in these e-liquids might lead to lung disease and other health problems.
Overall, although e-cigarettes may be less harmful than traditional smoking, they still pose significant risks. Considering these factors is important when deciding to join a clinical trial for e-cigarette flavors.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different e-cigarette flavors impact user experience and preferences, which could influence smoking cessation strategies. Unlike traditional cessation aids like nicotine patches or gum, this investigation looks at the sensory aspects of vaping — specifically how flavor variety might play a role in reducing smoking rates. By examining the effects of different e-liquid flavors, the trial aims to uncover insights that could lead to more personalized and potentially effective cessation tools for those looking to quit smoking.
What evidence suggests that this trial's treatments could be effective for influencing sensory effects and appeal of nicotine-containing e-cigs?
This trial will evaluate how different e-liquid flavors affect e-cigarette use. Studies have shown that e-liquid flavors can influence usage patterns. Flavored e-liquids often lead users to take more puffs and enjoy vaping more, likely due to taste preference. Research indicates that fruity flavors are popular and often prompt users to choose e-liquids with less nicotine. Flavors can also affect how quickly nicotine enters the body and can even alter heart rate. By reducing cravings, flavors can make vaping more appealing to some people. Participants in this trial will experience all three e-liquid flavors, with the order of flavors randomized across visits.36789
Who Is on the Research Team?
Danielle Davis
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for individuals aged 21-44 who currently smoke cigarettes and have used e-cigarettes at least 10 times in the past six months. Participants must be able to read/write, not planning to quit smoking soon, and willing to avoid nicotine/tobacco for 6-8 hours before lab sessions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants sample 3 different flavored e-cigarettes containing nicotine in a human lab paradigm across 3 visits
Follow-up
Participants are monitored for sensory effects, appeal, and reinforcing efficacy immediately after intervention
What Are the Treatments Tested in This Trial?
Interventions
- E-liquid Flavor 1
- E-liquid Flavor 2
- E-liquid Flavor 3
E-liquid Flavor 1 is already approved in European Union, United States for the following indications:
- Smoking cessation aid
- Smoking cessation aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator